SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Eloxx Pharmaceuticals Q1 EPS $(0.350) Misses $(0.300) Estimate

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.300) by 16.67 percent. This is a 6.06 percent decrease over losses of $(0.330) per

Benzinga · 05/07/2020 20:24

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(0.350) per share which missed the analyst consensus estimate of $(0.300) by 16.67 percent. This is a 6.06 percent decrease over losses of $(0.330) per share from the same period last year.